Correlation of fasting serum C-peptide and insulin with markers of metabolic syndrome-X in a homogeneous chinese population with normal glucose tolerance

International Journal of Cardiology

Volumn 68, Issue 2, 1999, Pages 179-186

  Chen, Chen Huan ^a,b   Tsai, Shih Tzer ^b   Chou, Pesus ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

C peptide; Epidemiology; Gender difference; Insulin; Insulin resistance

Indexed keywords

C PEPTIDE; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ARTICLE; CHINA; FEMALE; GENDER; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SYNDROME X;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; C-PEPTIDE; CHINA; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MICROVASCULAR ANGINA; MIDDLE AGED; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SEX CHARACTERISTICS;

EID: 0033611729     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(98)00366-0     Document Type: Article

References (47)

1. Reaven G.M. Role of insulin resistance in human disease. Diabetes. 37:1988;1595-1607.
2. Defronzo R.A., Ferranini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 14:1991;173-194.
3. Williams B. Insulin resistance: The shape of things to come. Lancet. 344:1994;521-524.
4. Reaven G.M., Lithell H., Landsberg L. Hypertension and associated metabolic abnormalities. The role of insulin resistance and the sympathoadrenal system. N Engl J Med. 334:1996;374-381.
5. Olefsky J.M. Insulin resistance and insulin action. Diabetes. 30:1981;148-162.
6. Laakso M. How good a marker is insulin level for insulin resistance. Am J Epidemiol. 137:1993;959-965.
7. Modan M., Halkin H., Almog S., Lusky A., Eshkol A., Shefi M. Hyperinsulinemia: A link between hypertension, obesity and glucose intolerance. J Clin Invest. 75:1985;809-817.
8. Giugliano D., Quatraro A., Minei A., De Rosa N., Coppola L., D'Onofrio F. Hyperinsulinemia in hypertension: Increased secretion, reduced clearance or both? J Endocrinol Invest. 16:1993;315-321.
9. Clark P.M.S., Hales C.N. How to measure plasma insulin. Diab Metab Rev. 10:1994;79-90.
10. O'Rahilly S., Burnett M.A., Smith R.E., Darley J.H., Turner R.C. Haemolysis affects insulin but not C-peptide immunoassay. Diabetologia. 30:1987;394-396.
11. Modan M., Or J., Karasik A.et al. Hyperinsulinemia, sex, and risk of atherosclerotic cardiovascular disease. Circulation. 84:1991;1165-1175.
12. Fontbonne A. Insulin. A sex hormone for cardiovascular risk? Circulation. 84:1991;1442-1444.
13. Chou P., Liao M.J., Kuo H.et al. Program description and preliminary health survey data in Kin-Ha, Kinmen. Chung Hua I Hsueh Tsa Chih (Taipei). 52:1993;241-248.
14. Chen C.H., Chuang J.H., Kuo H.S., Chang M.S., Wang S.P., Chou P. A population-based epidemiological study on cardiovascular risk factors in Kin-Chen Kinmen. Int J Cardiol. 48:1995;75-88.
15. Chen C.H., Tsai S.T., Chuang J.H., Chang M.S., Wang S.P., Chou P. Population-based study of insulin, C-peptide, and blood pressure in Chinese with normal glucose tolerance. Am J Cardiol. 76:1995;585-588.
16. Chou P., Wu G.S., Li C.L., Tsai S.T. Progression to type 2 diabetes among high-risk groups in Kin-Chen, Kinmen. Exploring the natural history of type 2 diabetes (abstract). Diabetes Care. 21:1998;1183-1187.
17. Boyko E.J., Keane E.M., Marshall J.A., Hamman R.F. Higher insulin and C-peptide concentrations in Hispanic population at high risk for NIDDM San Luis Valley Diabetes Study. Diabetes. 40:1991;509-515.
18. Saad M.F., Lillioja S., Nyomba B.L.et al. Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med. 324:1991;733-739.
19. Cruickshank J.K., Cooper J., Burnett M., MacDuff J., Drubra U. Ethnic differences in fasting plasma C-peptide and insulin in relation to glucose tolerance and blood pressure. Lancet. 338:1991;842-847.
20. Caro J.F. Insulin resistance in obese and non-obese man. J Clin Endocrinol Metab. 73:1991;691-695.
21. Kaplan N.M. The deadly quartet: Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med. 149:1989;1514-1520.
22. Haffner S.M., Fong D., Hazuda H.P., Pugh J.A., Patterson J.K. Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in non-diabetics. Metabolism. 37:1988;338-345.
23. Cambien F., Warnet J.-M., Eschwege E., Jacqueson A., Richard J.L., Rosselin G. Body mass, blood pressure, glucose, and lipids: Does plasma insulin explain their relationships? Arteriosclerosis. 7:1987;197-202.
24. Manolio T.A., Savage P.J., Burke G.L.et al. Association of fasting insulin with blood pressure and lipids in young adults: The CARDIA Study. Arteriosclerosis. 10:1990;430-436.
25. Modan M., Halkin H., Lusky A. Elevated serum uric acid-a facet of hyperinsulinaemia. Diabetologia. 30:1987;713-718.
26. Kesteloot H., Huang D.X., Yang X.S.et al. Serum lipids in the People's Republic of China: Comparison of western and eastern populations. Arteriosclerosis. 5:1985;427-433.
27. Sawicki P.T., Heinemann L., Starke A., Berger M. Hyperinsulinemia is not linked with blood pressure elevation in patients with insulinoma. Diabetologia. 35:1992;649-652.
28. Koutis A.D., Lionis C.D., Isacsson A., Jakobsson A., Fioretos M., Lindholm L.H. Characteristics of the Metabolic Syndrome X in a cardiovascular low risk population in Crete. Eur Heart J. 13:1992;865-871.
29. Pinkney J.H., Mohamed-Ali V., Denver A.E., Foster C., Sampson M.J., Yudkin J.S. Insulin resistance, insulin, proinsulin, and ambulatory blood pressure in type II diabetes. Hypertension. 24:1994;362-367.
30. Zavaroni I., Dall'Aglio E., Alpi O.et al. Evidence for an independent relationship between plasma insulin and concentration of high-density lipoprotein cholesterol and triglyceride. Atherosclerosis. 55:1985;259-266.
31. Asch S., Wingard D.L., Barrett-Connor E.L. Are insulin and hypertension independently related? Ann Epidemiol. 1:1991;231-244.
32. Licata G., Scaglione R., Ganguzza A.et al. Central obesity and hypertension. Relationship between fasting serum insulin, plasma renin activity, and diastolic blood pressure in young obese subjects. Am J Hypertens. 7:1994;314-320.
33. Mbanya J.-C.N., Thomas T.H., Wilkinson R., Alberti K.G.M.M., Taylor R. Hypertension and hyperinsulinemia: A relation in diabetes but not essential hypertension. Lancet. I:1988;733-734.
34. Takahashi H., Nakanishi T., Nishimura M., Fukumitsu S., Yoshimura M. Role of insulin in the pathogenesis of hypertension associated with glucose intolerance. Clin Exp Hypertens. 15:1993;575-584.
35. Every N.R., Marshall J.A., Boyko E.J., Rewers M., Keane E.M., Hamman R.F. Blood pressure, insulin, and C-peptide levels in San Luis Valley Colorado. Diabetes Care. 16:1993;1543-1550.
36. Shimokata H., Muller D.C., Fleg J.L., Sorkin J., Ziemba A.W., Andres R. Age as independent determinant of glucose tolerance. Diabetes. 40:1991;44-51.
37. Giugliano D., Salvatore T., Paolisso G.et al. Impaired glucose metabolism and reduced insulin clearance in elderly hypertensives. Am J Hypertens. 5:1992;345-353.
38. Burke G.L., Webber L.S., Sriivasan S.R., Radhakrishnamurthy B., Freedman D.S., Berenson G.S. Fasting plasma glucose and insulin levels and their relationship to cardiovascular risk factors in children: Bogalusa Heart Study. Metabolism. 35:1986;441-446.
39. Hebert P.R., Rich-Edwards J.W., Manson J.E.et al. Height and incidence of cardiovascular disease in male physicians. Circulation. 88(Part 1):1993;1437-1443.
40. Voors A.W., Webber L.S., Frerichs R.R., Berenson G.S. Body height and body mass as determinants of basal blood pressure in children - The Bogalusa Heart Study. Am J Epidemiol. 106:1977;101-108.
41. Brown D.C., Byrne C.D., Clark P.M.S.et al. Height and glucose tolerance in adult subjects. Diabetologia. 34:1991;531-533.
42. Hales CN. Metabolic consequences of intrauterine growth retardation, Acta Paediatrica 1997; Suppl 423:184-187.
43. Leger J., Levy-Marchal C., Bloch J.et al. Reduced final height and indications for insulin resistance in 20 year olds born small for gestational age: Regional cohort study. Br Med J. 315:1997;341-347.
44. Glueck C.J., Taylor H.L., Jacobs D., Morrison J.A., Beaglehole R., Williams O.D. Plasma high-density lipoprotein cholesterol: Association with measurements of body mass, the Lipid Research Clinics Program Prevalence Study. Circulation. 62(Suppl IV):1980;62-69.
45. Muller D.C., Elahi D., Pratley R.E., Tobin J.D., Andres R. An epidemiological test of the hyperinsulinemia-hypertension hypothesis. J Clin Endocrinol Metab. 76:1993;544-548.
46. Baba T., Kodama T., Tomiyama T., Sohn D.-R., Ishizaki I. Serum insulin level versus blood pressure: A cross-sectional, case-controlled study in non-obese, middle-aged Japanese subjects with normal glucose tolerance. Diabetic Med. 11:1994;42-49.
47. Facchii F.S., Hollenbeck C.B., Jeppesen J., Chen Y.-D., Reaven G.M. Insulin resistance and cigarette smoking. Lancet. 339:1992;1128-1130.